Journal of Separation Science · 2021 · 21 citations · 45 references
PharmacyPharmaceutical AnalysisPharmacologyAnalytical ChemistryAnalytical ToxicologyMass Spectrometric AnalysisCannabis ToxicologyChromatographyExtraction TechniquesInstrumental AnalysisLiquid ChromatographySolid-phase ExtractionHigh PermeabilityHigh-performance Liquid Chromatography-mass SpectrometryLiquid Chromatography-mass SpectrometryLiquid Chromatography-mass Spectrometry AnalysisLower Limit Of QuantificationLower Limit Of QuantitationSorptionSorption Capacity
Abstract This manuscript describes the development of an innovative method to determine cannabinoids (cannabidiol and tetrahydrocannabinol) in human plasma samples by pipette tip micro‐solid phase extraction and liquid chromatography‐mass spectrometry/mass spectromtery. An octyl‐functionalized hybrid silica monolith, which had been synthesized and characterized, was used as a selective stationary phase. The octyl‐functionalized hybrid silica monoliths presented high permeability and adequate mechanical strength. The micro‐solid phase extraction variables (sample pH, draw‐eject cycles, solvent for phase clean‐up, and desorption conditions) were investigated to improve not only the selectivity but also the sorption capacity. The method was linear at concentrations ranging from the lower limit of quantification (10.00 ng/mL) to the upper limit of quantification (150.0 ng/mL). The lack of fit and homoscedasticity tests, as well as the determination coefficients ( r 2 greater than 0.995), certified that linearity was adequate. The precision assays presented coefficient of variation values lower than 15%, and the accuracy tests provided relative error values ranging from 3.2 to 14%. Neither significant carry‐over nor matrix effects were detected. Therefore, the pipette tip micro‐solid phase extraction/liquid chromatography‐mass spectrometry/mass spectrometry method has demonstrated to be adequate to determine cannabidiol and tetrahydrocannabinol simultaneously in plasma samples for therapeutic drug monitoring of patients undergoing treatment with cannabinoids.
45
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
William A. Devane, Aviva Breuer, Roger G. Pertwee et al. · Science · 1992 · 5.6K citations
José Alemán, A. V. Chadwick, Jie He et al. · Pure and Applied Chemistry · 2007 · 802 citations · Full text
Natural Sciences, Materials Engineering, Materials Science +16